Publication:
COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine.

dc.contributor.authorLopez-Riquelme, Irene
dc.contributor.authorFernandez-Ballesteros, Maria Dolores
dc.contributor.authorSerrano-Ordoñez, Ana
dc.contributor.authorGodoy-Diaz, Daniel Jesus
dc.date.accessioned2023-05-03T13:28:45Z
dc.date.available2023-05-03T13:28:45Z
dc.date.issued2022-03-11
dc.description.versionSi
dc.identifier.citationLópez Riquelme I, Fernández Ballesteros MD, Serrano Ordoñez A, Godoy Díaz DJ. COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine. Dermatol Ther. 2022 Jul;35(7):e15502
dc.identifier.doi10.1111/dth.15502
dc.identifier.essn1529-8019
dc.identifier.pmcPMC9111626
dc.identifier.pmid35393710
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111626/pdf
dc.identifier.unpaywallURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111626
dc.identifier.urihttp://hdl.handle.net/10668/19938
dc.issue.number7
dc.journal.titleDermatologic therapy
dc.journal.titleabbreviationDermatol Ther
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.page.number2
dc.provenanceRealizada la curación de contenido 19/03/2025
dc.publisherWiley Periodicals LLC
dc.pubmedtypeLetter
dc.relation.publisherversionhttps://doi.org/10.1111/dth.15502
dc.rights.accessRightsRestricted Access
dc.subject.meshAutoimmune Diseases
dc.subject.meshCOVID-19
dc.subject.meshHumans
dc.subject.meshHypopigmentation
dc.subject.meshVaccines
dc.subject.meshVitiligo
dc.titleCOVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number35
dspace.entity.typePublication

Files